KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data on Oral On-Demand HAE Therapy KVD900 at AAAAI 2022
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today
United States Edwardj Duckworth Ben Palleiko Exchange Commission Kalvista Pharmaceuticals Inc American Academy Of Allergy
Source: finanznachrichten.de